✦ LIBER ✦

Pharmacokinetics and disposition of nifedipine and acebutolol as a fixed combination or given separately after single and repeated dose in healthy subjects

✍ Scribed by Desager, Jean-Pierre; Sclavons, Michel; Meunier, Henoch; Harvengt, Carl

Book ID: 122534946
Publisher: Elsevier Science
Year: 1986
Tongue: English
Weight: 324 KB
Volume: 31
Category: Article
ISSN: 0378-5173
DOI: 10.1016/0378-5173(86)90230-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of Amlodipine and Olmes

Pharmacokinetics of Amlodipine and Olmesartan After Administration of Amlodipine Besylate and Olmesartan Medoxomil in Separate Dosage Forms and as a Fixed-Dose Combination

✍ Rohatagi, Shashank; Lee, James; Shenouda, Magdy; Haworth, Stephen; Bathala, Mohi 📂 Article 📅 2008 🏛 Sage Publications 🌐 English ⚖ 163 KB

The pharmacokinetics of acebvutolol in m

The pharmacokinetics of acebvutolol in man, following the oral administration of acebutolol hcl as a single dose (400 mg), and during and after repeated oral dosing (400 mg, b.d.)

✍ A. A. Gulaid; I. M. James; C. M. Kaye; O. R. W. Lewellen; E. Roberts; M. Sankey; 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 508 KB

## Abstract The pharmacokinetics of acebutolol have been studied in eight healthy male volunteers following the oral administration of acebutolol hydrochloride (‘Sectral’, May & Baker) as a single dose (400 mg), and during and after repeated oral dosing (400 mg, b.d. for 56 days). Following single

The Pharmacokinetics and Safety of a Fix

The Pharmacokinetics and Safety of a Fixed-Dose Combination of Acetylsalicylic Acid and Clopidogrel Compared With the Concurrent Administration of Acetylsalicylic Acid and Clopidogrel in Healthy Subjects: A Randomized, Open-Label, 2-Sequence, 2-Period, Single-Dose Crossover Study

✍ Jung, Jin Ah; Kim, Tae-Eun; Kim, Jung-Ryul; Kim, Min-Ji; Huh, Wooseong; Park, Ky 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 196 KB

Pharmacokinetics and tolerability of sum

Pharmacokinetics and tolerability of sumatriptan after single-dose administration of a fixed-dose combination tablet of sumatriptan/naproxen sodium 85/500 mg followed two hours later by subcutaneous sumatriptan 4- or 6-mg injection: A randomized, open-label, three-period crossover study in healthy volunteers

✍ Alienor Berges; Christine Walls; Shelly E. Lener; Susan A. McDonald 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 151 KB